Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Circulation Research
|
April 11, 2015
Leptin beyond the lipostat: key component of blood pressure regulation
Christine M Kusminski, Philipp E Scherer
Annual Review of Physiology
|
November 15, 2024
A Mechanistic Rationale for Incretin-Based Therapeutics in the Management of Obesity
Ricardo J Samms, Christine M Kusminski
Science (New York, N.Y.)
|
July 27, 2019
Lowering ceramides to overcome diabetes
Christine M Kusminski, Philipp E Scherer
Trends in Endocrinology and Metabolism: TEM
|
July 13, 2012
Mitochondrial dysfunction in white adipose tissue
Christine M Kusminski, Philipp E Scherer
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2018
New zoning laws enforced by glucagon
Christine M Kusminski, Philipp E Scherer
The Journal of Clinical Investigation
|
June 3, 2011
Adipose tissue remodeling and obesity
Kai Sun, Christine M Kusminski, Philipp E Scherer
Clinical Science (London, England : 1979)
|
August 18, 2005
Role of resistin in obesity, insulin resistance and Type II diabetes
Christine M Kusminski, Philip G McTernan, Sudhesh Kumar
Current Opinion in Lipidology
|
March 15, 2006
Resistin
Philip G McTernan, Christine M Kusminski, Sudhesh Kumar
Trends in Pharmacological Sciences
|
April 11, 2009
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shoba Shetty, Christine M Kusminski, Philipp E Scherer
Circulation Research
|
January 7, 2021
Adiponectin, Leptin and Cardiovascular Disorders
Shangang Zhao, Christine M Kusminski, Philipp E Scherer
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Circulation Research
|
April 11, 2015
Leptin beyond the lipostat: key component of blood pressure regulation
Christine M Kusminski, Philipp E Scherer
Annual Review of Physiology
|
November 15, 2024
A Mechanistic Rationale for Incretin-Based Therapeutics in the Management of Obesity
Ricardo J Samms, Christine M Kusminski
Science (New York, N.Y.)
|
July 27, 2019
Lowering ceramides to overcome diabetes
Christine M Kusminski, Philipp E Scherer
Trends in Endocrinology and Metabolism: TEM
|
July 13, 2012
Mitochondrial dysfunction in white adipose tissue
Christine M Kusminski, Philipp E Scherer
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2018
New zoning laws enforced by glucagon
Christine M Kusminski, Philipp E Scherer
The Journal of Clinical Investigation
|
June 3, 2011
Adipose tissue remodeling and obesity
Kai Sun, Christine M Kusminski, Philipp E Scherer
Clinical Science (London, England : 1979)
|
August 18, 2005
Role of resistin in obesity, insulin resistance and Type II diabetes
Christine M Kusminski, Philip G McTernan, Sudhesh Kumar
Current Opinion in Lipidology
|
March 15, 2006
Resistin
Philip G McTernan, Christine M Kusminski, Sudhesh Kumar
Trends in Pharmacological Sciences
|
April 11, 2009
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shoba Shetty, Christine M Kusminski, Philipp E Scherer
Circulation Research
|
January 7, 2021
Adiponectin, Leptin and Cardiovascular Disorders
Shangang Zhao, Christine M Kusminski, Philipp E Scherer
Page
of 7